| # | Drug | Count |
|---|---|---|
| 0 | ROMIPLOSTIM | 90 |
| 1 | LENALIDOMIDE | 27 |
| 2 | PREDNISONE | 26 |
| 3 | ASPIRIN | 24 |
| 4 | ASPIRIN 325 MG | 23 |
| 5 | ASPIRIN 81 MG | 23 |
| 6 | RITUXIMAB | 23 |
| 7 | ACYCLOVIR | 21 |
| 8 | OMEPRAZOLE MAGNESIUM | 21 |
| 9 | ACETAMINOPHEN | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ROMIPLOSTIM | 90 | 0.0059 |
| 1 | DANAZOL | 4 | 0.0014 |
| 2 | PAMIDRONATE DISODIUM | 4 | 0.0012 |
| 3 | GEMTUZUMAB OZOGAMICIN | 4 | 0.0011 |
| 4 | 1168 BURN SPRAY | 3 | 0.0010 |
| 5 | ALLANTOIN | 3 | 0.0009 |
| 6 | ARSENIC TRIOXIDE | 2 | 0.0009 |
| 7 | EPOETIN ALFA | 9 | 0.0008 |
| 8 | DECITABINE | 3 | 0.0007 |
| 9 | CHLORAMBUCIL | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 90 |
| 1 | Corticosteroid [EPC] | 60 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 41 |
| 3 | Thalidomide Analog [EPC] | 32 |
| 4 | Kinase Inhibitor [EPC] | 27 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 27 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 25 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 24 |
| 8 | Proton Pump Inhibitor [EPC] | 24 |
| 9 | Benzodiazepine [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 90 | 0.0059 |
| 1 | CD33-directed Immunoconjugate [EPC] | 4 | 0.0011 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 3 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 4 | Human C1 Esterase Inhibitor [EPC] | 2 | 0.0005 |
| 5 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 6 | Sulfone [EPC] | 5 | 0.0005 |
| 7 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 8 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |